Form 4 for BDX Becton Dickinson
Accepted 2026-06-25 10:16:01 ET · period of report 2026-06-24 · accession 0001628280-26-045374 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-25 10:16 | 2026-06-24 | BDX | Garrison Michael David | EVP, Pres Med.Essntl, BioPharm | S - Sale | $145.66 | -1,100 | 13.2K | -8% | -$160.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-24 | S | D | 1,100 | $145.66 | 13,172 | D | — | — |